A mammalian insulysin homolog is regulated by enzyme IIAGlc of the glucose transport system in Vibrio vulnificus

FEBS Letters

Volumn 584, Issue 22, 2010, Pages 4537-4544

  Kim, You Jin ^a   Ryu, Yangkyun ^a   Koo, Byoung Mo ^a,d   Lee, Na Yeon ^b   Chun, Se Jin ^c   Park, Soon Jung ^b   Lee, Kyu Ho ^c   Seok, Yeong Jae ^a  

^a Seoul National University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Hankuk University of Foreign Studies   (South Korea)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Enzyme IIAGlc; Insulysin; Phosphoenolpyruvate:sugar phosphotransferase system; Protein protein interaction; Vibrio vulnificus

Indexed keywords

INSULINASE;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL GROWTH; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BINDING AFFINITY; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; GLUCOSE TRANSPORT SYSTEM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN TARGETING; VIBRIO VULNIFICUS;

ANIMALS; BIOLOGICAL TRANSPORT; FEMALE; GLUCOSE; HUMANS; INSULYSIN; MICE; MICE, INBRED ICR; PHOSPHOENOLPYRUVATE SUGAR PHOSPHOTRANSFERASE SYSTEM; PHOSPHORYLATION; SEQUENCE HOMOLOGY, AMINO ACID; SURVIVAL ANALYSIS; VIBRIO VULNIFICUS;

ESCHERICHIA COLI; MAMMALIA; VIBRIO VULNIFICUS;

EID: 78249244785     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.10.035     Document Type: Article

References (38)

1. Jones M.K., Oliver J.D. Vibrio vulnificus: disease and pathogenesis. Infect. Immun. 2009, 77:1723-1733.
2. Bisharat N., Cohen D.I., Harding R.M., Falush D., Crook D.W., Peto T., Maiden M.C. Hybrid Vibrio vulnificus. Emerg. Infect. Dis. 2005, 11:30-35.
3. Strom M.S., Paranjpye R.N. Epidemiology and pathogenesis of Vibrio vulnificus. Microbes Infect. 2000, 2:177-188.
4. Gulig P.A., Bourdage K.L., Starks A.M. Molecular pathogenesis of Vibrio vulnificus. J. Microbiol. 2005, 43:118-131.
5. Bisharat N., et al. Clinical, epidemiological, and microbiological features of Vibrio vulnificus biogroup 3 causing outbreaks of wound infection and bacteraemia in Israel. Israel Vibrio Study Group. Lancet 1999, 354:1421-1424.
6. Deutscher J., Francke C., Postma P.W. How phosphotransferase system-related protein phosphorylation regulates carbohydrate metabolism in bacteria. Microbiol. Mol. Biol. Rev. 2006, 70:939-1031.
7. Seok Y.-J., Sondej M., Badawi P., Lewis M.S., Briggs M.C., Jaffe H., Peterkofsky A. High affinity binding and allosteric regulation of Escherichia coli glycogen phosphorylase by the histidine phosphocarrier protein, HPr. J. Biol. Chem. 1997, 272:26511-26521.
8. Lee S.-J., Boos W., Bouche J.P., Plumbridge J. Signal transduction between a membrane-bound transporter, PtsG, and a soluble transcription factor, Mlc, of Escherichia coli. EMBO J. 2000, 19:5353-5361.
9. Glc recruits the global repressor Mlc. EMBO J. 2001, 20:491-498.
10. Tanaka Y., Kimata K., Aiba H. A novel regulatory role of glucose transporter of Escherichia coli: membrane sequestration of a global repressor Mlc. EMBO J. 2000, 19:5344-5352.
11. Glc interaction and a plausible molecular mechanism of Mlc inactivation by membrane sequestration. Proc. Natl. Acad. Sci. USA 2008, 105:3751-3756.
12. Park Y.-H., Lee B.R., Seok Y.-J., Peterkofsky A. In vitro reconstitution of catabolite repression in Escherichia coli. J. Biol. Chem. 2006, 281:6448-6454.
13. Glc in Escherichia coli. J. Biol. Chem. 2004, 279:31613-31621.
14. Glc with glycerol kinase. Science 1993, 259:673-677.
15. Wright A.C., Morris J.G., Maneval D.R., Richardson K., Kaper J.B. Cloning of the cytotoxin-hemolysin gene of Vibrio vulnificus. Infect. Immun. 1985, 50:922-924.
16. Milton D.L., O'Toole R., Horstedt P., Wolf-Watz H. Flagellin A is essential for the virulence of Vibrio anguillarum. J. Bacteriol. 1996, 178:1310-1319.
17. S in survival of exponential-phase cells under oxidative stress. J. Bacteriol. 2004, 186:3304-3312.
18. glc of the phosphoenolpyruvate:sugar phosphotransferase system of Mycoplasma capricolum. Biochemistry 1997, 36:6947-6953.
19. Reddy P., Peterkofsky A., McKenney K. Hyperexpression and purification of Escherichia coli adenylate cyclase using a vector designed for expression of lethal gene products. Nucleic Acids Res. 1989, 17:10473-10488.
20. Glc of Escherichia coli. Protein Expr. Purif. 1991, 2:179-187.
21. Nosworthy N.J., Peterkofsky A., Konig S., Seok Y.-J., Szczepanowski R.H., Ginsburg A. Phosphorylation destabilizes the amino-terminal domain of enzyme I of the Escherichia coli phosphoenolpyruvate:sugar phosphotransferase system. Biochemistry 1998, 37:6718-6726.
22. + transporter TrkA. Proc. Natl. Acad. Sci. USA 2007, 104:4124-4129.
23. Jeong J.-Y., Kim Y.-J., Cho N., Shin D., Nam T.-W., Ryu S., Seok Y.-J. Expression of ptsG encoding the major glucose transporter is regulated by ArcA in Escherichia coli. J. Biol. Chem. 2004, 279:38513-38518.
24. Nam T.-W., Park Y.-H., Jeong H.-J., Ryu S., Seok Y.-J. Glucose repression of the Escherichia coli sdhCDAB operon, revisited: regulation by the CRP-cAMP complex. Nucleic Acids Res. 2005, 33:6712-6722.
25. Glc, a component of the phosphoenolpyruvate:sugar phosphotransferase system, to the Escherichia coli lactose permease. Biochemistry 2002, 41:5556-5565.
26. Glc with regulatory target protein glycerol kinase: substitutions of a Zinc(II) ligand and implications for inducer exclusion. Biochemistry 1998, 37:4875-4883.
27. Authier F., Posner B.I., Bergeron J.J. Insulin-degrading enzyme. Clin. Invest. Med. 1996, 19:149-160.
28. Bennett R.G., Duckworth W.C., Hamel F.G. Degradation of amylin by insulin-degrading enzyme. J. Biol. Chem. 2000, 275:36621-36625.
29. Ding L., Becker A.B., Suzuki A., Roth R.A. Comparison of the enzymatic and biochemical properties of human insulin-degrading enzyme and Escherichia coli protease III. J. Biol. Chem. 1992, 267:2414-2420.
30. McDermott J.R., Gibson A.M. Degradation of Alzheimer's β-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme. Neurochem. Res. 1997, 22:49-56.
31. Sarada B., Thiele D., Dang T., Lee J., Safavia A., Hersh L.B., Cottam G.L. Anti-CD3 activation of human CD4+ T cells increases expression of the intracellular β-endorphin endopeptidase (IDE/γ-EpGE) J. Neuroimmunology 1998, 85:59-68.
32. Goo S.Y., et al. Identification of OmpU of Vibrio vulnificus as a fibronectin-binding protein and its role in bacterial pathogenesis. Infect. Immun. 2006, 74:5586-5594.
33. Blake P.A., Merson M.H., Weaver R.E., Hollis D.G., Heublein P.C. Disease caused by a marine Vibrio. Clinical characteristics and epidemiology. N. Engl. J. Med. 1979, 300:1-5.
34. Mertins S., et al. Interference of components of the phosphoenolpyruvate phosphotransferase system with the central virulence gene regulator PrfA of Listeria monocytogenes. J. Bacteriol. 2007, 189:473-490.
35. Shelburne S.A., Keith D., Horstmann N., Sumby P., Davenport M.T., Graviss E.A., Brennan R.G., Musser J.M. A direct link between carbohydrate utilization and virulence in the major human pathogen group A Streptococcus. Proc. Natl. Acad. Sci. USA 2008, 105:1698-1703.
36. Tsvetanova B., Wilson A.C., Bongiorni C., Chiang C., Hoch J.A., Perego M. Opposing effects of histidine phosphorylation regulate the AtxA virulence transcription factor in Bacillus anthracis. Mol. Microbiol. 2007, 63:644-655.
37. Wright A.C., Simpson L.M., Oliver J.D., Morris J.G. Phenotypic evaluation of acapsular transposon mutants of Vibrio vulnificus. Infect. Immun. 1990, 58:1769-1773.
38. Simon R., Priefer U., Puhler A. A broad host range mobilization system for in vivo genetic-engineering - transposon mutagenesis in gram-negative bacteria. Bio/Technology 1983, 1:784-791.